These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24037226)

  • 1. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.
    Müller RG; Haase N; Wetterslev J; Perner A
    Intensive Care Med; 2013 Nov; 39(11):1963-71. PubMed ID: 24037226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.
    Perner A; Haase N; Winkel P; Guttormsen AB; Tenhunen J; Klemenzson G; Müller RG; Aneman A; Wetterslev J
    Intensive Care Med; 2014 Jul; 40(7):927-34. PubMed ID: 24807084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.
    Anthon CT; Müller RB; Haase N; Hjortrup PB; Møller K; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2017 Sep; 61(8):904-913. PubMed ID: 28653377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
    Müller RB; Haase N; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.
    Perner A; Haase N; Guttormsen AB; Tenhunen J; Klemenzson G; Åneman A; Madsen KR; Møller MH; Elkjær JM; Poulsen LM; Bendtsen A; Winding R; Steensen M; Berezowicz P; Søe-Jensen P; Bestle M; Strand K; Wiis J; White JO; Thornberg KJ; Quist L; Nielsen J; Andersen LH; Holst LB; Thormar K; Kjældgaard AL; Fabritius ML; Mondrup F; Pott FC; Møller TP; Winkel P; Wetterslev J; ;
    N Engl J Med; 2012 Jul; 367(2):124-34. PubMed ID: 22738085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl starch in severe sepsis: end of starch era?
    Estrada CA; Murugan R
    Crit Care; 2013 Mar; 17(2):310. PubMed ID: 23509901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
    Hjortrup PB; Haase N; Wetterslev J; Perner A
    PLoS One; 2016; 11(5):e0155767. PubMed ID: 27196104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.
    Perner A; Haase N; Wetterslev J; Aneman A; Tenhunen J; Guttormsen AB; Klemenzson G; Pott F; Bødker KD; Bådstøløkken PM; Bendtsen A; Søe-Jensen P; Tousi H; Bestle M; Pawlowicz M; Winding R; Bülow HH; Kancir C; Steensen M; Nielsen J; Fogh B; Madsen KR; Larsen NH; Carlsson M; Wiis J; Petersen JA; Iversen S; Schøidt O; Leivdal S; Berezowicz P; Pettilä V; Ruokonen E; Klepstad P; Karlsson S; Kaukonen M; Rutanen J; Karason S; Kjældgaard AL; Holst LB; Wernerman J;
    Trials; 2011 Jan; 12():24. PubMed ID: 21269526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.
    Wittbrodt P; Haase N; Butowska D; Winding R; Poulsen JB; Perner A; ;
    Crit Care; 2013 Feb; 17(2):R58. PubMed ID: 23531324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.
    Haase N; Wetterslev J; Winkel P; Perner A
    Intensive Care Med; 2013 Dec; 39(12):2126-34. PubMed ID: 24081433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate.
    Müller RB; Ostrowski SR; Haase N; Wetterslev J; Perner A; Johansson PI
    J Crit Care; 2016 Apr; 32():16-20. PubMed ID: 26810483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature.
    Serpa Neto A; Veelo DP; Peireira VG; de Assunção MS; Manetta JA; Espósito DC; Schultz MJ
    J Crit Care; 2014 Feb; 29(1):185.e1-7. PubMed ID: 24262273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
    Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
    Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock].
    Lyu J; Li T; Liu F; An Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):28-32. PubMed ID: 25591433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multi-centre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality.
    Crystalloid versus Hydroxyethyl Starch Trial (CHEST) Management Committee
    Intensive Care Med; 2011 May; 37(5):816-23. PubMed ID: 21308360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
    Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann A; Ragaller M; Weiler N; Moerer O; Gruendling M; Oppert M; Grond S; Olthoff D; Jaschinski U; John S; Rossaint R; Welte T; Schaefer M; Kern P; Kuhnt E; Kiehntopf M; Hartog C; Natanson C; Loeffler M; Reinhart K;
    N Engl J Med; 2008 Jan; 358(2):125-39. PubMed ID: 18184958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystalloids vs. colloids: KO at the twelfth round?
    Phillips DP; Kaynar AM; Kellum JA; Gomez H
    Crit Care; 2013 May; 17(3):319. PubMed ID: 23731998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of resuscitation with hydroxyethyl starch and lactated Ringers on macrophage activity after hemorrhagic shock and sepsis.
    Oelschlager BK; Caragnano C; Carpenter J; Baker CC
    Shock; 1994 Aug; 2(2):141-4. PubMed ID: 7537166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.